Larimar Therapeutics (LRMR) Current Leases (2019 - 2025)
Larimar Therapeutics (LRMR) posted Current Leases of $1.1 million for Q4 2025, down 4.0% on a QoQ basis from $1.2 million in Q3 2025, and up 4.25% year-over-year from $1.1 million in Q4 2024.
Larimar Therapeutics (LRMR) Current Leases (2019 - 2025) Analysis & Trends
Larimar Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $1.1 million for Q4 2025.
- Quarterly Current Leases rose 4.25% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (up 4.25% YoY) and the FY2025 annual result came in at $1.1 million, up 4.25% from the prior year.
- Current Leases was $1.1 million for Q4 2025 at Larimar Therapeutics, down from $1.2 million in the prior quarter.
- Across five years, Current Leases topped out at $1.2 million in Q3 2025 and bottomed at $534000.0 in Q1 2021.
- A 5-year average of $791800.0 and a median of $673000.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases declined 11.29% — and 2024, when it surged 75.27%.
- Larimar Therapeutics' Current Leases stood at $594000.0 in 2021, then rose by 2.86% to $611000.0 in 2022, then jumped by 36.99% to $837000.0 in 2023, then climbed by 26.64% to $1.1 million in 2024, then rose by 4.25% to $1.1 million in 2025.
- Business Quant data shows LRMR's Current Leases at $1.1 million in Q4 2025, $1.2 million in Q3 2025, and $1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.61 Mn |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | 1.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 992,000.00 |
| Mar 31, 2024 | 825,000.00 |
| Dec 31, 2023 | 837,000.00 |
| Sep 30, 2023 | 708,000.00 |
| Jun 30, 2023 | 566,000.00 |
| Mar 31, 2023 | 589,000.00 |
| Dec 31, 2022 | 611,000.00 |
| Sep 30, 2022 | 632,000.00 |
| Jun 30, 2022 | 638,000.00 |
| Mar 31, 2022 | 616,000.00 |
| Dec 31, 2021 | 594,000.00 |
| Sep 30, 2021 | 574,000.00 |
| Jun 30, 2021 | 553,000.00 |
| Mar 31, 2021 | 534,000.00 |